Scynexis, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Durham NC United States (1999)

Organization Overview

First Clinical Trial
2007
NCT01290965
First Marketed Drug
2021
scy-078
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

SCYNEXIS | Scynexis, Inc.